GI CIS high yield handout 1 Flashcards
annual screening of tnf-a inhib
ppd, hepatitis panel, derm exam
what is reynold’s pentad
charcots plus mental status changes and hypotension
what is ascending cholangitits
infection of biliary tract secondary to bile duct obstruction or bile stasis
courvoisiers sign
enlarged non tender GB secondary to pancreatic disease or cancer
what is the treatment of ascending cholangitis
urgent ERCP (within 12-24 hrs) -sphincterotomy (cut spchincter of oddi slightly) with stone removal or stent placement
antibitoics
supportive care like IV fluids
pancreas level
T5-11
protective of gallstones
low carb diet physical activity caffeinated coffee (in women) high intake of Mg and polyunsat and monunsat fats (men) high fiber diet and statin therapy ASA and NSAIDs
espohagus level
T2-8
gallbladder level
T6-9
grey turner sign
flank ecchymosis secondary to hemmorrhage
when do you suspect choledocholithiasis on ultrasound
how big
normal in non eldery
elderly can get up to
when common bile duct is over 6mm
normal in non eldery with an intact GB is 3-6mm
eldery or post cholecystemcoty can get up to 10mm
murphys sign tests for
acute cholecystitis or cholelithiasis
what are some possible complications status post ERCP
pancreatitis
ascending cholangitis
hemobilia, perforation, bile leaks (less common these 3)
what labs should be ordered for cholantitis
AST/ALT, alk phos, fractionated bilirubin, amylase/lipase
pre-procdeure INR
follow up on blood culture and bile culture that were ordered and pending
possible side effects of TNF-a inhibtiors
infections: bacgerial infections (pneumonia) zoster, TB, opportunisitc
cutaneous rxn: at injection site or psoriasis, eczema, SLE, lichen planus
malignancy (lymphma and skin cancer)
induction of autoimmunity: autoimmune hepatitis, drug induced SLE, psoriatic skin lesion, intersitial lung disease, MS, sarcoid
parasyp levels upper portion
esophagus through transverse colon
OA,AA (vagus n)
alternative empiric regimen for cholangitis
fluorquin plus metronidazole
cipro or levoflox plus metronidazole
monotherpay with carbapenem
lab screening TNF-a inhib
CNC with differential, CMP every 2 months